Celon Pharma in the Stock Exchange Company of the Year ranking

Celon Pharma took 2nd place in the Development prospects category in the 22nd edition of the Stock Exchange Company of the Year 2020.

The GSR report was prepared on the basis of an assessment of companies in the course of a special online survey in which companies & nbsp; to be assessed in accordance with the professional competences of the respondents.

The subject of the evaluation of companies from the full evaluation were; e.g. the level of knowledge of a given company, competences of the management board, relations with investors, broadly understood success in 2020, recommendation to purchase the company's shares, the company's innovation, development prospect.